Abstract:Zhihua Zhang, 1 Yuhong Wang, 2 Yankun Zhang, 3 Shujun Geng, 2 Haifeng Wu, 4 Yanxin Shao, 5 Guannan Kang 6 1 Department of Science & Education, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 2 Department of Tuberculosis, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 3 Department of Ophthalmology, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 4 Clinical Laboratory, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 5 Office of Clinical Pharmacological Center, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 6 Department of Tuberculosis, Hebei Chest Hospital, Shijiazhuang, People's Republic of China Correspondence: Yanxin Shao, Office of Clinical Pharmacological Center, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, No. 372, Sheng Li North Street, Shijiazhuang, Hebei, 050041, People's Republic of China, Email Background: Tuberculosis (TB) is one of the most infectious diseases caused by Mycobacterium tuberculosis ( M. tb ), and the diagnosis of active tuberculosis (TB) and latent TB infection (LTBI) remains challenging. Methods: Gene expression files were downloaded from the GEO database to identify the differentially expressed genes (DEGs). The ssGSEA algorithm was applied to assess the immunological characteristics of patients with LTBI and TB. Weighted gene co-expression network analysis, protein-protein interaction network, and the cytoHubba plug-in of Cytoscape were used to identify the real hub genes. Finally, a diagnostic model was constructed using real hub genes and validated using a validation set. Results: Macrophages and natural killer cells were identified as important immune cells strongly associated with TB. In total, 726 mRNAs were identified as DEGs. MX1, STAT1, IFIH1, DDX58, and IRF7 were identified as real hub immune-related genes. The diagnostic model generated by the five real hub genes could distinguish active TB from healthy controls or patients with LTBI. Conclusion: Our study may provide implications for the diagnosis and drug development of M. tb infections. Keywords: tuberculosis, latent tuberculosis infection, mycobacterium tuberculosis , immune, diagnostic model Tuberculosis (TB), a chronic disease caused by Mycobacterium tuberculosis ( M. tb ), is the leading cause of death from a single infectious agent (ranking above HIV/AIDS). 1 Globally, there were 6.4 million newly diagnosed TB cases and 1.4 million deaths caused by TB in 2021. 2 The disease typically affects the lungs (pulmonary TB) but can also affect other sites (extrapulmonary TB). Indeed, approximately 90% of infected people do not display clinical symptoms and not contagious, and are in a state known as "latent TB infection" (LTBI). 3 The fine line between TB and LTBI is the presence or absence of clinical symptoms, imaging changes, and bacteriological evidence of active TB. LTBI is the reservoir of the TB epidemic. 4 Of those infected with TB, approximately 5–10% will develop TB during their lifetime. 5 The World Health Organization (WHO) "End Tuberculosis Strategy" recommended that early diagnosis and treatment of LTBI patients at a higher risk of infection was essential to effectively control TB globally. 6 The tuberculin skin test fails to distinguish patients with LTBI from those with TB and people who have received Bacillus Calmette-Guérin vaccination. 7 The lack of biomarkers to distinguish active TB from LTBI limited the progress in TB control. The latest data indicated that lack of differential diagnosis of LTBI and TB may be a potential reason for the high morbidity and mortality in countries with a high TB burden. 8 Therefore, the development of rapid, simple, and cost-effective diagnostic tests is imperative for TB control. 9 Innate immunity plays an essential role in mediating the initial host response to M. tb infections. The course of infection and disease development largely depends on the early interactions between M. tb and the host innate immune system. 10 Innate immune cells are the first to encounter M. tb , such as macrophages, dendritic cells, neutrophils, and natural killer cells. 11 Macrophages are the first immune cells to encounter M. tb and -Abstract Truncated-

A modified multiple-criteria decision-making approach based on a protein-protein interaction network to diagnose latent tuberculosis

Decoding the similarities and specific differences between latent and active tuberculosis infections based on consistently differential expression networks

Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

A Diagnostic Model for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection Based on the Blood Expression Profiles of Autophagy-Related Genes

Human gene expression profiling identifies key therapeutic targets in tuberculosis infection: A systematic network meta-analysis

Novel Biomarkers Distinguishing Active Tuberculosis From Latent Infection Identified By Gene Expression Profile Of Peripheral Blood Mononuclear Cells

Coexpression Network Analysis-Based Identification of Critical Genes Differentiating Between Latent and Active Tuberculosis.

Profiling the Mrna and Mirna in Peripheral Blood Mononuclear Cells in Subjects with Active Tuberculosis

Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection

Cost-Effective Whole Transcriptome Sequencing Landscape and Diagnostic Potential Biomarkers in Active Tuberculosis

Predictive nomogram of high-risk patients with active tuberculosis in latent tuberculosis infection

Screening of Biological Biomarker for Distinguishing Latent and Active Tuberculosis by Proteome Microarray

A proteomics approach to the identification of plasma biomarkers for latent tuberculosis infection.

A multidimensional network-based approach to elucidate the molecular mechanism underlying tuberculosis and HIV coinfection

Identification of apoptosis-related gene signatures as potential biomarkers for differentiating active from latent tuberculosis via bioinformatics analysis

Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection

Construction of Immune-Related Diagnostic Model for Latent Tuberculosis Infection and Active Tuberculosis

Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates Mycobacterium tuberculosis Infection Status: An Exploratory Study

Identification of active molecules against Mycobacterium tuberculosis through machine learning

Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis